News & Blog


Biotech Daily (newsletter) – Imagion, GCT work on nano-scintillator for breast cancer

Thursday August 12, 2021 Daily news on ASX-listed biotechnology companies * AS X FLAT, BIOTECH…


Imagion Biosystems (ASX:IBX) up on deal to develop breast cancer treatment

Shares of Imagion Biosystems (ASX:IBX) jumped as much as 9% to AU$0.085, their highest since…


Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer

Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement…


Phoenix and Maricopa County Proclaim July 21st as Glioblastoma Awareness Day

PHOENIX, July 21, 2021 /PRNewswire/ — In recognition of the local strides being made in the…


San Diego company aiming to target glioblastoma with nanotechnology-based approach

The emerging biopharmaceutical company Global Cancer Technology (GCT; San Diego) is…


Global Cancer Technology Appoints Chief Scientific Consultant and Advisor

GCT strengthens science development team with top appointment of biotech and…


BioSpace Movers & Shakers

Biopharma and life sciences organizations strengthen their leadership teams and board with…


What Will It Take to Bring Glioblastoma Research to the Forefront?

Dr. Loralyn Mears is the Director of Scientific Communications for Global Cancer Technology, and..


Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment

Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical…


Partnerships at Barrow Neurological Institute to Commercialize New Glioblastoma Treatment

Together with scientists from the University of California San Diego, Global Cancer Technology (GCT)…


Global Cancer Technology Signs Agreement with Barrow Neurological Institute to Commercialize

Global Cancer Technology Signs Agreement with Barrow Neurological Institute to…


A Novel Treatment Modality for COVID-19

Global Cancer Technology is Developing a Light-emitting Nanoparticle Which May…